Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Structural identifiability of "first-pass" models.

A Venot, E Walter, Y Lecourtier

Journal of Pharmacokinetics and Biopharmaceutics

|April 1, 1987

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Experimental Observation of the Motion of Ions in a Resonantly Driven Plasma Wakefield Accelerator.

Physical review letters·2025

Same author

Visualization of Pulpal Structures by SWIR in Endodontic Access Preparation.

Journal of dental research·2024

Same author

Filamentation of a relativistic proton bunch in plasma.

Physical review. E·2024

Same author

Correction to: Histamine, mast cell tryptase and post-exercise hypotension in healthy and collapsed marathon runners.

European journal of applied physiology·2021

Same author

Ca<sup>2+</sup> signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus.

The British journal of dermatology·2021

Same author

Histamine, mast cell tryptase and post-exercise hypotension in healthy and collapsed marathon runners.

European journal of applied physiology·2021

Same journal

Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Journal of pharmacokinetics and biopharmaceutics·2010

Same journal

Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Journal of pharmacokinetics and biopharmaceutics·2010

Same journal

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

Journal of pharmacokinetics and biopharmaceutics·2010

Same journal

Pharmacokinetics of methotrexate in solid tumors.

Journal of pharmacokinetics and biopharmaceutics·2010

Same journal

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Journal of pharmacokinetics and biopharmaceutics·2010

Same journal

Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Journal of pharmacokinetics and biopharmaceutics·2010

See all related articles

Structural identifiability analysis of oral drug pharmacokinetics reveals the simplest model is not globally identifiable, requiring prior knowledge. A more complex model demonstrates global identifiability with blood and urine data.

Area of Science:

Pharmacokinetics
Systems Biology
Mathematical Modeling

Background:

Compartmental models are essential for understanding drug behavior in the body.
First-pass metabolism significantly impacts oral drug bioavailability.
Structural identifiability is crucial for reliable model parameter estimation.

Purpose of the Study:

To assess the structural identifiability of two pharmacokinetic models for orally administered drugs with hepatic first-pass effects.
To determine if plasma, urine, and blood measurements can ensure global identifiability.

Main Methods:

Analysis of structural identifiability for two distinct compartmental models.
Evaluation of model identifiability using simulated plasma, urine, and blood concentration-time data for drug and metabolite.

Related Experiment Videos

Application of mathematical techniques to identify structural non-identifiabilities.

Main Results:

The simpler pharmacokinetic model was found to be structurally non-identifiable, even with combined plasma and urine data.
Two distinct sets of admissible solutions were identified for the simpler model, necessitating additional a priori information.
The more complex pharmacokinetic model was determined to be structurally globally identifiable when utilizing blood and urine measurements.

Conclusions:

Simple pharmacokinetic models may not be sufficient for accurate drug behavior description.
Integrating diverse data sources (blood, urine) can improve model identifiability.
Complex models may be necessary to fully capture drug metabolism and ensure reliable pharmacokinetic analysis.